IMpassion130, Solar-1 Trial Data

IMpassion130, Solar-1 Trial Data

Cancer-News

1 year
77 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Hope Rugo, M.D., University Of California San Francisco discusses IMpassion130, Solar-1 Trial Data. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Up Next Autoplay
Pacific Brain Tumor Center Recruiting Patients with Rare Cancer of the Skull and Spine for Groundbreaking Clinical Trial
Pacific Brain Tumor Center Recruiting Patients with Rare Cancer of the Skull and Spine for Groundbreaking Clinical Trial
Category: Brain Cancer
5 Views
Cancer-News 1 week
Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
Category: Brain Cancer
6 Views
Cancer-News 2 weeks
Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
Category: Brain Cancer
15 Views
alexvarney 2 months
Predicting Tumor Recurrence: How Does This Help Us?
Predicting Tumor Recurrence: How Does This Help Us?
Category: Brain Cancer
9 Views
Baylor College of Medicine 3 months
Predicting Tumor Recurrence
Predicting Tumor Recurrence
Category: Brain Cancer
20 Views
Baylor College of Medicine 3 months
How does this affect clinicians today?
How does this affect clinicians today?
Category: Brain Cancer
10 Views
Cleveland Clinic 4 months
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
Category: Brain Cancer
25 Views
Cleveland Clinic 4 months
Oncoceutics Commemorates National Childhood Cancer Awareness Month
Oncoceutics Commemorates National Childhood Cancer Awareness Month
Category: Brain Cancer
19 Views
alexvarney 4 months
Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
Category: Brain Cancer
39 Views
alexvarney 4 months
Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206
Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206
Category: Brain Cancer
42 Views
alexvarney 4 months